Insights

Innovative Technology Platform Meditope Biosciences has developed the proprietary SnAP antibody platform, which offers precise and versatile molecule conjugation capabilities. This cutting-edge technology can be leveraged by healthcare and biotech companies seeking advanced targeted therapeutics or diagnostic tools.

Collaborative Potential The company's partnership with Sanofi highlights opportunities for joint development and co-innovation in bioconjugation and immuno-oncology, opening avenues for collaboration with other large pharma and biotech firms interested in antibody engineering.

Focused Oncology Pipeline Meditope’s preclinical pipeline targeting prostate and bladder cancers presents potential for strategic alliances, licensing deals, and investment from organizations looking to expand into emerging cancer immunotherapies.

Market Niche Opportunity Operating within a competitive landscape of biotech firms with similar or larger revenue, Meditope’s unique antibody platform offers a differentiated value proposition that can appeal to specialized partners focusing on novel bioconjugate therapeutics and personalized medicine.

Meditope Biosciences, Inc. Tech Stack

Meditope Biosciences, Inc. uses 8 technology products and services including Google Cloud CDN, Wix, WordPress, and more. Explore Meditope Biosciences, Inc.'s tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Wix
    Content Management System
  • WordPress
    Content Management System
  • MySQL
    Database
  • Webpack
    Development
  • TweenMax
    Javascript Frameworks
  • WebsiteBuilder
    Page Builders
  • WordPress.com
    Platform As A Service

Media & News

Meditope Biosciences, Inc.'s Email Address Formats

Meditope Biosciences, Inc. uses at least 1 format(s):
Meditope Biosciences, Inc. Email FormatsExamplePercentage
First@meditope.comJohn@meditope.com
40%
First-Last@meditope.comJohn-Doe@meditope.com
10%
FirstLast@meditope.comJohnDoe@meditope.com
10%
First@meditope.comJohn@meditope.com
40%

Frequently Asked Questions

Where is Meditope Biosciences, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc.'s main headquarters is located at 177 East Colorado Boulevard Pasadena, California 91105 United States. The company has employees across 1 continents, including North America.

What is Meditope Biosciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Meditope Biosciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Meditope Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc.'s official website is meditope.com and has social profiles on LinkedInCrunchbase.

What is Meditope Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Meditope Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Meditope Biosciences, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Chief Financial Officer: M. H.President And Chief Executive Officer: M. L.. Explore Meditope Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Meditope Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Meditope Biosciences, Inc. use?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc.'s tech stack includes Google Cloud CDNWixWordPressMySQLWebpackTweenMaxWebsiteBuilderWordPress.com.

What is Meditope Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Meditope Biosciences, Inc.'s email format typically follows the pattern of First@meditope.com. Find more Meditope Biosciences, Inc. email formats with LeadIQ.

How much funding has Meditope Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, Meditope Biosciences, Inc. has raised $3.6M in funding. The last funding round occurred on Jul 26, 2013 for $3.6M.

Meditope Biosciences, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Meditope Biosciences, Inc. is in possession of a revolutionary antibody platform technology called “SnAP” (Site-specific, novel, Antibody Platform), which can turn antibodies into a LEGO-like system. The power, elegance, and simplicity of SnAP allows for a broad range of molecules – toxins, proteins, radiolabels, other antibodies – to be ‘snapped’ on or off an antibody with predictability, precision and control. Meditope is using this technology to develop a preclinical pipeline of compelling cancer drugs including two new immuno-oncology product for prostate and bladder cancers.

Section iconCompany Overview

Headquarters
177 East Colorado Boulevard Pasadena, California 91105 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $3.6M

    Meditope Biosciences, Inc. has raised a total of $3.6M of funding over 1 rounds. Their latest funding round was raised on Jul 26, 2013 in the amount of $3.6Mas a Series A.

  • $1M

    Meditope Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $3.6M

    Meditope Biosciences, Inc. has raised a total of $3.6M of funding over 1 rounds. Their latest funding round was raised on Jul 26, 2013 in the amount of $3.6Mas a Series A.

  • $1M

    Meditope Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.